PFE saw its Momentum Indicator move below the 0 level on August 02, 2022. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 50 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 60%.
The Moving Average Convergence Divergence Histogram (MACD) for PFE turned negative on July 18, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
PFE moved below its 50-day moving average on July 28, 2022 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PFE crossed bearishly below the 50-day moving average on July 25, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PFE entered a downward trend on August 05, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .
PFE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.353) is normal, around the industry mean (5.287). P/E Ratio (9.515) is within average values for comparable stocks, (90.885). Projected Growth (PEG Ratio) (1.110) is also within normal values, averaging (3.290). Dividend Yield (0.032) settles around the average of (0.028) among similar stocks. P/S Ratio (2.796) is also within normal values, averaging (3.758).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a manufacturer of vaccines and injectable biologic medicines
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with LLY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then LLY could also see price increases.
|LLY - PFE|
|BMY - PFE|
|JNJ - PFE|
|ABBV - PFE|
|NVS - PFE|